Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model. [electronic resource]
Producer: 20191212Description: 281-291 p. digitalISSN:- 2373-8227
- Administration, Intravenous
- Animals
- Anti-Bacterial Agents -- pharmacokinetics
- Disease Models, Animal
- Female
- Francisella tularensis -- drug effects
- Injections, Intramuscular
- Mice
- Mice, Inbred BALB C
- Moxifloxacin -- pharmacokinetics
- Nanoparticles -- administration & dosage
- Pneumonia, Bacterial -- drug therapy
- Tularemia -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.